Ventyx Biosciences, Inc. 4/A SEC Filings

Filed On	Filing
04 Aug 2023	Form 4/A: Krueger Christopher W, Chief Business Officer Exercised 15,000 Stock Option (Right to Buy)
19 Jul 2023	Form 4/A: Nsv Partners Iii Lp, 10% owner and 1 other Sold 75,686 shares ($2.65M) · Sold 24,314 shares ($875K) · Disposed of 964,178 shares (Other Transaction)
19 Jul 2023	Form 4/A: Subramaniam Somu, Director Sold 100,000 shares ($3.52M) · Disposed of 964,178 shares (Other Transaction)
04 May 2023	Form 4/A: Krueger Christopher W, Chief Business Officer Received 8,447 shares by exercise or conversion ($32K) · Sold 15,000 shares ($493K)
27 Apr 2023	Form 4/A: Cadoret-Manier Onaiza, Director Granted 20,427 Stock Option (right to buy)
26 Apr 2023	Form 4/A: Royston Aaron, Director Granted 21,825 Stock Option (right to buy)
26 Apr 2023	Form 4/A: Hulme Allison, Director Granted 20,427 Stock Option (right to buy)
26 Apr 2023	Form 4/A: Subramaniam Somu, Director Granted 21,825 Stock Option (right to buy)
26 Apr 2023	Form 4/A: Gujrathi Sheila, Director Granted 21,825 Stock Option (right to buy)
26 Apr 2023	Form 4/A: White William Richard, Director Granted 21,825 Stock Option (right to buy)
01 Jul 2022	Form 4/A: Choksey Jigar, Director Holds 0 Stock Option (right to buy)

Comments